Log In
Print this Print this

Ebola tablet vaccine

  Manage Alerts
Collapse Summary General Information
Company Vaxart Inc.
DescriptionTablet vaccine containing an adenovirus serotype 5 (Ad5) vector encoding an Ebola antigen and a toll-like receptor 3 (TLR3) ligand
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationEbola
Indication DetailsTreat Ebola virus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today